erythrosine has been researched along with ritonavir in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drewe, J; Fricker, G; Gutmann, H; Miller, DS; Toeroek, M | 1 |
Arimori, K; Fujii, J; Hamada, A; Nakano, M; Shiraki, N; Yasuda, K | 1 |
Annaert, P; Augustijns, P; Camus, S; Snoeys, J; Van Pelt, J; Ye, ZW | 1 |
Annaert, P; Augustijns, P; Camus, S; Ye, ZW | 1 |
Abbès, S; Bissinger, R; Bouguerra, G; Lang, F; Waibel, S | 1 |
Arimany-Nardi, C; Cedeño, S; Clotet, B; Erkizia, I; Martinez-Picado, J; Minuesa, G; Moltó, J; Pastor-Anglada, M | 1 |
6 other study(ies) available for erythrosine and ritonavir
Article | Year |
---|---|
Interactions of HIV protease inhibitors with ATP-dependent drug export proteins.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclosporine; Fluoresceins; HIV Protease Inhibitors; Killifishes; Methotrexate; Mitochondrial Proteins; Ribosomal Proteins; Ritonavir; Saccharomyces cerevisiae Proteins; Saquinavir | 1999 |
Inhibitory effect of human immunodeficiency virus protease inhibitors on multidrug resistance transporter P-glycoproteins.
Topics: Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Drug Interactions; Fluoresceins; Fluorescent Dyes; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Kinetics; LLC-PK1 Cells; Nelfinavir; Reverse Transcriptase Inhibitors; Ritonavir; Swine; Transfection | 2000 |
Species-specific interaction of HIV protease inhibitors with accumulation of cholyl-glycylamido-fluorescein (CGamF) in sandwich-cultured hepatocytes.
Topics: Animals; Bile Acids and Salts; Biological Transport; Darunavir; Dogs; Dosage Forms; Female; Fluoresceins; Hepatocytes; HIV Protease Inhibitors; Humans; Indinavir; Liver; Male; Middle Aged; Rats; Rats, Wistar; Ritonavir; Species Specificity; Sulfonamides; Sus scrofa | 2010 |
Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytes.
Topics: Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carbamates; Cells, Cultured; Fluoresceins; Furans; Hepatocytes; HIV Protease Inhibitors; Humans; Indinavir; Liver; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nelfinavir; Rats; Rats, Wistar; Ritonavir; Saquinavir; Sulfonamides | 2010 |
Ritonavir-Induced Suicidal Death of Human Erythrocytes.
Topics: Annexin A5; Apoptosis; Calcium; Cell Size; Ceramides; Erythrocyte Membrane; Erythrocytes; Fluoresceins; Humans; Oxidative Stress; Phosphatidylserines; Reactive Oxygen Species; Ritonavir | 2016 |
P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.
Topics: Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; Benzylidene Compounds; CD4-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Fluoresceins; Healthy Volunteers; HIV Infections; HIV-1; Humans; Immunologic Memory; Raltegravir Potassium; Ritonavir; Tetrahydroisoquinolines; Viral Load; Viremia; Virus Replication | 2016 |